Dihydrothymine - Revision history

Prab at 20:27, 16 March 2025

2025-03-16T20:27:52Z

← Older revision		Revision as of 20:27, 16 March 2025
Line 15:		Line 15:
	[[Category:Nucleic acids]]		[[Category:Nucleic acids]]
	{{chemistry-stub}}		{{chemistry-stub}}
	~~{{No image}}~~
	~~{{No image}}~~
	<gallery>		<gallery>
	File:5,6-Dihydrothymin.svg\|5,6-Dihydrothymin structure		File:5,6-Dihydrothymin.svg\|5,6-Dihydrothymin structure
	</gallery>		</gallery>

Prab: CSV import

2025-03-03T05:18:31Z

CSV import

← Older revision		Revision as of 05:18, 3 March 2025
Line 17:		Line 17:
	{{No image}}		{{No image}}
	{{No image}}		{{No image}}
			<gallery>
			File:5,6-Dihydrothymin.svg\|5,6-Dihydrothymin structure
			</gallery>

Prab: CSV import

2025-02-10T14:38:44Z

CSV import

← Older revision		Revision as of 14:38, 10 February 2025
Line 15:		Line 15:
	[[Category:Nucleic acids]]		[[Category:Nucleic acids]]
	{{chemistry-stub}}		{{chemistry-stub}}
			{{No image}}
	{{No image}}		{{No image}}

Prab: CSV import

2025-02-10T14:38:10Z

CSV import

← Older revision		Revision as of 14:38, 10 February 2025
Line 15:		Line 15:
	[[Category:Nucleic acids]]		[[Category:Nucleic acids]]
	{{chemistry-stub}}		{{chemistry-stub}}
			{{No image}}

Prab: CSV import

2024-03-25T02:24:41Z

CSV import

New page

{{png-image}}

'''Dihydrothymine''' is a [[chemical compound]] that plays a significant role in the [[metabolism]] of [[nucleic acids]]. It is a reduced form of [[thymine]], one of the four [[nucleobases]] used in the synthesis of [[DNA]]. Dihydrothymine is involved in the [[pyrimidine metabolism]] pathway, which is crucial for the synthesis and degradation of [[pyrimidine]] nucleotides.

The conversion of thymine to dihydrothymine is catalyzed by the enzyme [[dihydropyrimidine dehydrogenase]] (DPD), which is a key enzyme in the catabolism of thymine and [[uracil]], another pyrimidine nucleobase. This reaction is part of the process by which cells recycle nucleic acid components.

Dihydrothymine accumulation in the body is associated with a rare genetic disorder known as [[Dihydropyrimidinuria]]. This condition results from a deficiency in dihydropyrimidine dehydrogenase, leading to elevated levels of dihydrothymine and other pyrimidine metabolites in the urine. Patients with dihydropyrimidinuria may exhibit a range of symptoms, including developmental delays, seizures, and, in some cases, intellectual disability. The severity of symptoms can vary widely among affected individuals.

The detection of elevated dihydrothymine levels in urine is used diagnostically to identify dihydropyrimidinuria. Treatment strategies for this condition are primarily supportive and aimed at managing symptoms, as there is currently no cure for dihydropyrimidinuria.

In addition to its role in human metabolism and disease, dihydrothymine is also of interest in the field of [[biochemistry]] for its applications in research, particularly in studies related to DNA synthesis and repair mechanisms.

[[Category:Biochemistry]]
[[Category:Metabolism]]
[[Category:Nucleic acids]]
{{chemistry-stub}}